Showing results (41-50 of 121) with videos related to
Sort By:
Pageof 13
3 Biotech|May 26, 2025
Identification of AKTIP as a biomarker for fibrolamellar carcinoma using WGCNA and machine learningRui Wang, Bo Ren, Xijie Zhang, et al.Frontiers in Immunology|April 23, 2025
Pancreatic cancer subtyping - the keystone of precision treatmentZeyang Fan, Yao Xiao, Yan Du, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 20, 2024
Current status of neoadjuvant immunotherapy for the treatment of gastric cancerXijie Zhang, Bo Liu, Rui Wang, et al.BMC Public Health|February 13, 2024
Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030Ru He, Wenkai Jiang, Chenyu Wang, et al.Translational Cancer Research|September 12, 2024
Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3pZhou Chen, Yan Du, Huaqing Shi, et al.Frontiers in Oncology|May 2, 2022
Challenges and Opportunities Associated With Platelets in Pancreatic CancerZhou Chen, Xiaodong Wei, Shi Dong, et al.Scientific Reports|April 28, 2025
Global incidence and mortality of pancreatitis in women of childbearing age from 1990 to 2021Wenkai Jiang, Ru He, Huiqi Sun, et al.Journal of Personalized Medicine|March 29, 2023
Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic CancerYan Du, Lin Zhu, Xin Li, et al.Biomolecules|October 27, 2022
STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic CancerXin Li, Wenkai Jiang, Shi Dong, et al.BMC Cancer|September 18, 2023
Time trend of pancreatic cancer mortality in the Western Pacific Region: age-period-cohort analysis from 1990 to 2019 and forecasting for 2044Wenkai Jiang, Caifei Xiang, Yan Du, et al.Pageof 13